Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial

Author:

Chen Christopher L.H.,Lu Qingshu,Moorakonda Rajesh Babu,Kandiah Nagaendran,Tan Boon Yeow,Villaraza Steven Gayoles,Cano Jemelle,Venketasubramanian Narayanaswamy

Funder

Government of Singapore Ministry of Health

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference47 articles.

1. Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors;Catindig;J Neurol Sci,2012

2. World Alzheimer Report 2015. The global impact of dementia: an analysis of prevalence, incidence, costs and trends. www.alz.co.uk/worldreport2015 Accessed August 8, 2021.

3. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis;Hansen;Clin Interv Aging,2008

4. Current and future treatments for Alzheimer's disease;Yiannopoulou;Ther Adv Neurol Disord,2013

5. Neuroprotective and neuroproliferative activities of NeuroAiD (MLC601, MLC901), a Chinese medicine, in vitro and in vivo;Heurteaux;Neuropharmacology,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3